Credo Technology CEO Sells $12 Million in Shares
CRDO has more than doubled off its 52-week low of $66.75 on elevated volume (2.1× avg).
Summary
Credo Technology Group's CEO, William Joseph Brennan, sold $12 million in company shares, adding to a trend of insider selling despite recent positive corporate news.
Key Events · Ownership and Investor Activity · CRDO
-
CEO Sells Significant Stake
William Joseph Brennan, President & CEO, disposed of 54,984 ordinary shares for a total value of $12,017,877 on June 5, 2026.
-
Contributes to Insider Selling Trend
This transaction is part of a larger pattern of insider distribution, with over $50 million in net insider sales reported by four insiders in the past 90 days.
-
Amidst Positive Company Developments
The sale occurs following recent positive news, including a patent settlement, the acquisition of DustPhotonics, and strong Q4 FY26 revenue growth and Q1 guidance.
Analysis · CRDO · Manufacturing
William Joseph Brennan, Credo Technology's President and CEO, sold over $12 million worth of company shares. This significant personal liquidity event contributes to a broader trend of insider distribution, with over $50 million in net insider sales reported across four insiders in the last 90 days. While the company has recently announced positive developments like a patent settlement, a major acquisition, and strong financial results, this executive sale could be interpreted as profit-taking or a cautious signal amidst the positive news flow.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRDO was trading at $235.32 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $43.2B. The 52-week trading range was $66.75 to $252.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.